Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Piramal Pharma Limited has informed the stock exchanges about its upcoming schedule of meetings with analysts and institutional investors. This intimation is filed as a regulatory requirement under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The company is sharing details of planned interactions with the investor community, which typically include one-on-one or group meetings. No specific financial numbers, business updates, or strategic announcements are mentioned in this intimation; it merely discloses the schedule of engagement. Investors interested in the detailed meeting schedule should refer to the attached document filed with the exchanges.
This is a routine compliance filing and is unlikely to move the stock price on its own. However, investors should monitor for any management commentary, guidance updates, or strategic insights that may be shared during these analyst and investor meetings.